Medical drugstore. Online drugs shop. Internet pharmacy.
RobustHealth.org : Online pharmacy drugstore Drugstore shopping cart
Your cart
0 items ($0.00)
HOME BEST ALL LIST SHIPPING HELP CONTACTS CART
Language: us uk it es fr de
Currency: USD EUR AUD GBP CAD CHF
Add to Favorites
 
   Main categories
 
 
   Generic drugs news

22.10.2011
Generics in the United Kingdom - Performance of the Market Is Forecast To Decelerate, With an Anticipated CAGR Of 7.9% for the Five-Year Period 2010... [reading]

22.10.2011
The US Generics Market Had Total Revenue of $71.4 Billion in 2010, Representing A CAGR Of 8.2% between 2006 and 2010 [reading]

21.10.2011
Antares Pharma Granted New U.S. Patent Covering VIBEX? Injector Technology [reading]

21.10.2011
Drugs giants probed by EU anti-trust authority [Deutsche Welle] [reading]

20.10.2011
CMS` Transparency Push Could Revolutionize Drug Pricing [reading]

19.10.2011
Perrigo confirms filing for generic version of PATANASE nasal spray [reading]

19.10.2011
Pharmacists to Federal Medicaid Officials: Revamp Proposed Generic Drug Federal Upper Limits to Preserve Pharmacy Access for Patients [reading]

19.10.2011
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.; Analysis of Agreement Containing Consent Orders To Aid Public Comment [reading]

18.10.2011
Perrigo applies to FDA for generic nasal spray [reading]

18.10.2011
Watson confirms filing ANDA for generic version of Warner`s Atelvia [reading]

18.10.2011
Watson confirms filing ANDA with FDA for generic version of Noven`s Daytrana [reading]

17.10.2011
New NCPA Ads Feature Community Pharmacy Proposals to Reduce the Federal Deficit [reading]


 

Generic drugs news


Antares Pharma Granted New U.S. Patent Covering VIBEX? Injector Technology


21.10.2011

Antares Pharma, Inc. (NYSE Amex:AIS) announced that U.S. Patent number 8,021,335 has been granted by United States Patent and Trademark Office (USPTO), covering technology used in the Company`s VIBEX? platform of needle-assisted jet injection devices. The patent provides protection for the VIBEX technology until 2027. Antares` VIBEX platform is the basis for several products in development by Antares including VIBEX MTX, the first auto-injector in development to potentially enable rheumatoid arthritis patients to comfortably and safely self-inject methotrexate at home. Antares is a leading U.S. developer of novel and advanced self-injection products including needle-free injectors and pen devices in addition to VIBEX (see also Medical Device Companies).

Paul K. Wotton, PhD, President & Chief Executive Officer of Antares Pharma, stated, "The strength and breadth of Antares` patent portfolio continues to build. The issuance of this important, broad patent to enhance the intellectual property protecting products developed using our VIBEX platform will strengthen the potential commercial value of VIBEX MTX, as well as the products we are currently developing in collaboration with Teva Pharmaceuticals. Importantly, as we look at the emerging biosimilars market, VIBEX addresses the growing need for product differentiation among similar therapeutic agents, as our delivery technology provides patients with easy-to-administer, safe and effective self-injection options." About VIBEX? The VIBEX system is designed to economically provide highly reliable subcutaneous injections comfortably and conveniently in conjunction with the enhanced safety of an integrated shielded needle. VIBEX employs a proprietary coil-spring power source to rapidly deliver the prescribed medication. This spring is combined with a tiny hidden needle in a disposable, single-use injection system compatible with conventional syringes. After use, the device can be disposed of without the typical "sharps" disposal concerns. Antares and its development partners have successfully tested the device in patient preference and clinical bioavailability studies. Antares continues to explore product extensions including multiple dose and variable dose applications as well as integrated reconstitution systems for lyophilized drugs. About Methotrexate Used in an estimated 70% of patients alone and in combination with biological therapies, MTX is a foundational disease-modifying anti-rheumatic drug (DMARD) for RA. Generally initiated orally at lower doses and titrated up, published studies have reported as many as 30% to 60% of patients experience gastrointestinal side effects with oral MTX. This can prevent further dose escalation or require discontinuation in some patients which can be avoided by subcutaneous administration.

The extent of oral absorption of MTX varies considerably between patients and has been shown to decline with increasing doses. Studies have also reported that switching patients from oral to parenteral MTX improves absorption providing superior therapeutic response resulting in longer duration of use.



 

 Related news

 
15.08.2009 Antares Pharma Receives Payment from Teva for Commercial Development of Vibex Auto-Injector Product
2009 AUG 16 - (NewsRx.com) Antares Pharma, Inc. (NYSE Amex: AIS) announced that it has received a payment from Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), which will be applied to the design and purchase of commercial tooling and...
 
01.12.2010 Antares Pharma Announces Next Generation of Auto-Injector Design
Antares Pharma, Inc. (NYSE Amex:AIS), a leader in self-injection drug delivery technology, announced the latest advancement in its proprietary line of VIBEX? auto-injectors (see also Pharmaceutical Companies).Antares` new VIBEX QS...
 
17.11.2009 Big Pharma seeks to insulate itself from impact of patent cliff
Nov 18, 2009 (Datamonitor via COMTEX) The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose patent protection and become exposed to generic competition. While companies are...
 
07.12.2009 Analyst: Pharma profit will fall on patent losses
NEW YORK-Pharmaceutical companies relying on blockbuster drugs to fuel their profits could suffer more damage from generic competition in the next several years than Wall Street expects, a Bernstein Research analyst says.In a report...
 
10.06.2010 Big Pharma seeks to insulate itself from impact of patent cliff
The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose patent protection and become exposed to generic competition.Big Pharma seeks to insulate itself from impact of patent...
 
   Most popular drugs

Viagra - is a world-known medication used to help men overcome erectile dysfunction (ED). Viagra is sold under various trade names like Sildenafil citrate, Revation and others depending on the country it is distributed in. Viagra is also prescribed for the treatment of pulmonary arterial hypertension.
25mg, 50mg, 100mg tablets
[ordering Sildenafil]

Cialis - do you suffer from ED and want to get an effective treatment for it? Tadalafil citrate is a medication specifically formulated to treat impotence in men. Moreover, it is known for its long-lasting effect, what gives an opportunity to have fruitful sexual experience at any time convenient to you and your partner.
5 mg, 10 mg, 40 mg pills
[ordering Tadalafil]

Levitra - also known as Vardenafil, is an erectile dysfunction medication. It works by relaxing penis blood vessels and letting the blood flow easily, thus it helps to maintain erection.
Dosages: 10mg, 20mg
[ordering Vardenafil]

VPXL - is a real godsend for men with small penis. VPXL is a herbal medication used to increase penis size. [ordering VPXL]

Propecia - is a drug prescribed to men suffering from intense hair loss.
Dosages: 1 mg, 5mg
[ordering Propecia]

Xenical - is prescribed as a dietary supplement to people suffering from corpulence. For better results it is recommended to use Xenical alongside low calorie diet and exercises. Xenical works by blocking the fat in the blood and help to reduce fat intake.
Doses: 60 mg, 120 mg
[ordering Xenical]

Acomplia - are you tired of excess weight? Are you afraid of other more serious medical conditions that can be caused by obesity? Acomplia was specifically formulated to help you avoid these problems. Acomplia is an effective remedy used for the treatment of corpulence.
Weght: 20 mg
[ordering Acomplia]

Tamiflu - is an antiviral drug used for the treatment of flu symptoms in patients suffering from influenza. Tamiflu is known for its fast relieving effect upon the virus.
Dose: 75 mg
[ordering Tamiflu]

 
 
   Help and FAQ

What's the difference between generic drugs and brand-name drugs?
Actually, they both differ only in price and name, all the rest is the same. Generic drugs, as well as brand-name medications, have the same dosage, effects, including side effects, risks, strength and safety. They are like true copies of brand-name medications.

What makes generic drugs cheaper?
As a rule, in order to release and patent a certain drug the manufacturer should meet a range of requirements like developing, researching, marketing and promoting of a new medication. Overall, it is time- and money-consuming procedure, which leads to price growth. Speaking about generic drugs, they are usually brought unregistered onto the market, thus the manufacturer is exempt from paying taxes. However, the lower price here doesn't yield lower effectiveness. As a rule, the manufacturers of generic drugs are known reputable pharmaceutical companies.

What credit cards do you accept?
We accept Visa, MasterCard, AmEx, Diners and JCB cards.

Do you ship Internationally?
Yes, we ship Internationally at this time.

Order delay at customs: what to do?
It may happen that your order can be delayed at customs. In this case customs officers usually ask the recipient to come to the office and permit them to open a parcel in order to examine it. After this they give a parcel to the recipient. If you still have problems with getting your order, contact us so that we can help you solve this problem.

 
 
Home | All drugs | Shipping | Moneyback | Privacy | Antispam | FAQ | Contact us VisaDinersJCBeCHECK